The study involved four major activities in estimating the current size of the breast reconstruction market. Exhaustive secondary research was conducted to collect information on the market and its different sub segments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub segments
How the market Growth Impact in terms of revenue?
The Global Breast Reconstruction Market size is projected to reach USD 603 million by 2025, at a CAGR of 7.0% during the forecast period.
Breast Reconstruction Market, Growth Factor Analysis:
· Rising incidence of breast cancer
· Increasing awareness
· Reimbursements for breast reconstruction
· Development of 3D-printed implants
Speak to Our Research Analyst, to resolve your Queries:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=186501593
Breast implants accounted for the largest share of the market
Based on the product, the breast reconstruction market is segmented into breast implants, tissue expanders, and acellular dermal matrix. The breast implants segment accounted for the largest market share in 2019.
The immediate procedures segment accounted for the largest market share in 2019.
Based on the procedure, the breast reconstruction market is segmented into immediate, delayed, and revision procedures. The immediate procedures segment accounted for the largest market share in 2019. This is primarily attributed to the increasing number of surgeries post-mastectomy and rising awareness.
Recent Developments
· In 2019, Polytech Health & Aesthetics received US FDA approval for its textured breast implants (macrotextured and polyurethane-coated implants)
· In 2018, J&J launched CPX4 breast tissue expander
· In 2018, Polytech Health & Aesthetics merged with G&G Biotechnology
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186501593
By region, the breast reconstruction market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. This is attributed to factors such as the rising incidences of breast cancer, increasing awareness of breast reconstruction, and FDA approvals for breast reconstruction products
The prominent players operating in the global breast reconstruction market are Johnson & Johnson (US), Allergan (Ireland), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), Polytech Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (Costa Rica), and Silimed (Brazil).